Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 14
Review
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,506 | Dovepress* | 9,726+ | 430 | 10,156 | |
| PubMed Central* | 5,780 | 722 | 6,502 | ||
| Totals | 15,506 | 1,152 | 16,658 | ||
| *Since 29 April 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar